Desirudin Recombinant
Generic Name: desirudin recombinant
Manufactured by BAUSCH. Dosage form: INJECTABLE. Route: SUBCUTANEOUS. Active ingredients: DESIRUDIN RECOMBINANT (15MG/VIAL). Application: BLA021271.
Overview
Manufactured by BAUSCH. Dosage form: INJECTABLE. Route: SUBCUTANEOUS. Active ingredients: DESIRUDIN RECOMBINANT (15MG/VIAL). Application: BLA021271.
Dosage
Available as injectable for subcutaneous use.
Related Medications
Menthol 1%
menthol 1%
Topical Analgesic
Glycyrrhiza Glabra, Plantago Major, Stillingia Sylvatica, Trifolium Pratense, Arnica Montana, Asclepias Tuberosa, Berberis Vulgaris, Calendula Officinalis, Chamomilla, Chelidonium Majus, Echinacea (angustifolia), Eucalyptus Globulus, Lappa Major, Nasturtium Aquaticum, Phytolacca Decandra, Rhamnus Frangula, Rhamnus Purshiana, Taraxacum Officinale, Trigonella Foenum-graecum, Urtica Dioica, Xanthoxylum Fraxineum, Symphytum Officinale, Hepar Suis, Lung (suis), Lymph Node (suis)
glycyrrhiza glabra, plantago major, stillingia sylvatica, trifolium pratense, arnica montana, asclepias tuberosa, berberis vulgaris, calendula officinalis, chamomilla, chelidonium majus, echinacea (angustifolia), eucalyptus globulus, lappa major, nasturtium aquaticum, phytolacca decandra, rhamnus frangula, rhamnus purshiana, taraxacum officinale, trigonella foenum-graecum, urtica dioica, xanthoxylum fraxineum, symphytum officinale, hepar suis, lung (suis), lymph node (suis)
Non-Standardized Food Allergenic Extract [EPC]
HOMEOPATHIC INDICATIONS: For temporary relief of cough with sensation as if something were loose in the chest, rhinitis, hoarseness with rough, scraped feeling of the throat & stuffiness of the nose as a consequence of industrial pollutants.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Brinzolamide/brimonidine Tartrate
brinzolamide/brimonidine tartrate
Carbonic Anhydrase Inhibitor [EPC]
11 DESCRIPTION SIMBRINZA (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist for topical ophthalmic use. Brinzolamide is described chemically as: (R)-(+)-4-Ethylamino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno [3,2-e]-1,2-thiazine-6-sulfonamide-1,1- dioxide.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.